ConductScience.org, home

Trial · NCT07877389

Predicting Declines in Attention and Memory During a Prolonged Mental Task

NCT07877389, Not applicable, Not yet recruiting, DSW Ideis University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Predicting Declines in Attention and Memory During a Prolonged Mental Task. Trials, record NCT07877389. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07877389

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Predicting Declines in Attention and Memory During a Prolonged Mental Task
NCT number
NCT07877389
Status
Not yet recruiting
Phases
Not applicable
Enrollment
250 participants, estimated
Lead sponsor
DSW Ideis University
Conditions
Mental Fatigue, Cognitive Performance
Interventions
Individually Calibrated Time Load Dual-back Task With Seated Rest
First posted
2026-10-16
Last updated
2026-10-16

Source ClinicalTrials.gov

Registered outcomes16

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryWeighted Accuracy During the Final Four Minutes of the Main Cognitive TaskDuring seconds 720-960 (the final four minutes) of the 16-minute main task, within a single study visit.
Weighted accuracy (WAcc) on the Time Load Dual-back task is calculated as 0.65 x letter accuracy + 0.35 x digit accuracy, with both component accuracies expressed as percentages. Letter accuracy includes correct responses to matching letters and correct withholding of responses to nonmatching letters. Digit accuracy is the percentage of correct odd/even classifications. Errors and required-response omissions are scored as incorrect. The first letter of each new sequence and technically excluded trials are removed from the relevant denominators; analytical windows do not reset the letter reference. Scores range from 0 to 100%, with higher scores indicating better performance. The primary endpoint is the late-task score; initial accuracy is included as a predictor, rather than subtracted to define this endpoint.
SecondaryWeighted Accuracy Across the Main Cognitive TaskDuring four consecutive 4-minute windows (0-240, 240-480, 480-720, and 720-960 seconds) of the 16-minute main task.
Weighted accuracy is calculated separately for each consecutive four-minute window as 0.65 x percentage letter accuracy + 0.35 x percentage digit accuracy. Correct letter responses include both target detections and correct withholding on non-target trials. The scoring and exclusion rules are identical to those for the primary outcome. Scores range from 0 to 100%, with higher scores indicating better performance. The repeated scores describe the course of performance during sustained cognitive load.
SecondaryChange in Weighted Accuracy From the End of the Main Task to the Post-Rest TaskDuring the entire 4-minute task after five minutes of seated rest; compared with seconds 720-960 of the 16-minute main task.
Weighted accuracy during the entire four-minute post-rest task minus weighted accuracy during the final four minutes of the main task, expressed in percentage points. Both scores use the same weighting (0.65 x letter accuracy + 0.35 x digit accuracy), scoring rules, and individually calibrated presentation interval. The difference ranges from -100 to +100 percentage points. Positive values indicate better accuracy after rest. This comparison describes change after the break without attributing the change solely to rest.
SecondaryMedian Correct-Response Reaction Time Across Task PhasesDuring each of four consecutive 4-minute windows of the 16-minute main task and during the entire 4-minute post-rest task, within one visit.
Within-participant median time from stimulus onset to the first keypress on a correctly scored response-required trial, in milliseconds, calculated separately for each assessment window. Only correct trials requiring a response are included; correct withholding on non-target letter trials has no reaction time. Responses earlier than 100 ms and technically excluded trials are not included. Response times must fall within the stimulus response window. Main-task trajectories and post-rest versus late-main-task values will be compared. Shorter times indicate faster responses and will be interpreted together with accuracy.
SecondaryStandard Deviation of Correct-Response Reaction Time Across Task PhasesDuring each of four consecutive 4-minute windows of the 16-minute main task and during the entire 4-minute post-rest task, within one visit.
Within-participant sample standard deviation of correct-response reaction times, in milliseconds, calculated separately for each assessment window. The same eligible responses are used as for median correct-response reaction time: correct keypresses from 100 ms after stimulus onset to the end of the response window. Correct withholding, anticipations, incorrect responses, and technically excluded trials are not included. Higher values indicate greater variability in response speed. Main-task trajectories and post-rest versus late-main-task values will be compared.
SecondaryNumber of Incorrect Responses Across Task PhasesDuring each of four consecutive 4-minute windows of the 16-minute main task and during the entire 4-minute post-rest task, within one visit.
Number of trials with an incorrect keypress in each assessment window, including responses to non-target letters, incorrect response keys on letter-target or digit trials, and anticipatory responses earlier than 100 ms. A trial is scored once according to the first-keypress rule. Required-response trials without a keypress are counted separately as omissions; correct withholding on non-target letters is not an error. Technically excluded trials and the first reference-setting letter of each sequence are omitted. Counts will be interpreted with the number of eligible trials, which varies with the calibrated presentation interval. Lower counts indicate fewer incorrect responses.
SecondaryNumber of Required-Response Omissions Across Task PhasesDuring each of four consecutive 4-minute windows of the 16-minute main task and during the entire 4-minute post-rest task, within one visit.
Number of letter-target and digit trials in which no keypress is recorded within the response window. Correct withholding on non-target letter trials is not an omission. Trials with anticipatory or incorrect keypresses are classified as incorrect responses rather than omissions. Technically excluded trials and the first reference-setting letter of each sequence are omitted. Counts will be interpreted with the number of eligible response-required trials. Main-task trajectories and post-rest versus late-main-task values will be compared. Lower counts indicate fewer omissions.
SecondarySelf-Reported Mental Fatigue Across the Study Visit
Before baseline; after calibration/before the main task; immediately after the 16-minute main task; after five minutes of rest/before the post-rest task; and immediately after the 4-minute post-rest task, within one visit.
Single-item rating of current mental fatigue from 0 (no mental fatigue) to 100 (extreme mental fatigue). Ratings are obtained before baseline, after calibration immediately before the main task, immediately after the main task, after the full five-minute rest before the post-rest task, and after the post-rest task. Repeated ratings describe fatigue during preparation, sustained task performance, rest, and task resumption. Higher scores indicate greater fatigue.
SecondaryPerceived Workload on the Unweighted NASA Task Load IndexImmediately after the 16-minute main task and before the start of the five-minute seated rest.
Unweighted mean of the six ratings on the National Aeronautics and Space Administration Task Load Index (NASA-TLX): mental demand, physical demand, temporal demand, performance, effort, and frustration. Each dimension is scored from 0 to 100. The performance dimension is oriented from success to failure so that higher values on every dimension indicate greater workload or a less favorable assessment. The overall score ranges from 0 to 100, with higher scores indicating greater perceived workload. Ratings refer only to the 16-minute main task. Pairwise weighting is not used.
SecondaryHeart Rate Variability During Baseline, Cognitive Load, and RestDuring seconds 60-300 of the 5-minute baseline, each consecutive 4-minute window of the 16-minute main task, and seconds 60-300 of the 5-minute seated rest.
Root mean square of successive differences between normal-to-normal heartbeat intervals (RMSSD), in milliseconds, calculated from quality-controlled electrocardiographic recordings using continuous valid segments. Values are calculated separately for each assessment window. The natural logarithm of RMSSD is used in the predictive model; early reactivity is the first main-task window minus baseline on that logarithmic scale. Resting recovery compares the final four minutes of seated rest with the final four minutes of the main task and baseline. Higher RMSSD indicates greater successive-interval variability, without implying better cognitive performance.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers8

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
26715686BACKGROUNDPubMed
26973501BACKGROUNDPubMed
28237888BACKGROUNDPubMed
28265249BACKGROUNDPubMed
31680632BACKGROUNDPubMed
33657124BACKGROUNDPubMed
36414673BACKGROUNDPubMed
40777221BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07877389

GET https://conductscience.org/api/trials/v1/NCT07877389/registered